Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy

Thousands of cancer patients are currently in clinical trials evaluating antiangiogenic therapy in the neoadjuvant setting, which is the treatment of localized primary tumors prior to surgical intervention. The rationale is that shrinking a tumor will improve surgical outcomes and minimize growth of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebos, John ML, Mastri, Michalis, Lee, Christina R, Tracz, Amanda, Hudson, John M, Attwood, Kristopher, Cruz-Munoz, William R, Jedeszko, Christopher, Burns, Peter, Kerbel, Robert S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287975/
https://www.ncbi.nlm.nih.gov/pubmed/25361689
http://dx.doi.org/10.15252/emmm.201403989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287975/
https://www.ncbi.nlm.nih.gov/pubmed/25361689
http://dx.doi.org/10.15252/emmm.201403989

Ejemplares similares